Trial Profile
The observation of clinical changes when using dapagliflozin in type 2 diabetes patients having long course, receiving high doses of insulin and with diabetic nephropathy and poor glycemic control.
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 22 Jan 2018
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- 22 Jan 2018 New trial record